Skip to main content

Published locations for Refractory metastatic CRC: Raltitrexed plus S-1 betters regorafenib in prolonging survival

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Refractory metastatic CRC: Raltitrexed plus S-1 betters regorafenib in prolonging survival

User login

  • Reset your password
  • /content/refractory-metastatic-crc-raltitrexed-plus-s-1-betters-regorafenib-prolonging-survival
  • /hematology-oncology/article/255623/gastrointestinal-cancer/refractory-metastatic-crc-raltitrexed